VYNE
VYNE Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.59
+0.00 +0.66%
🌙 3월 13일 6:42 PM ET (한국 3/14 07:42)
$0.59
+0.00 -0.22%
| Index | - | P/E | - | EPS (ttm) | -0.65 | Insider Own | 5.83% | Shs Outstand | 0.03B | Perf Week | -0.64% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | 5.84% | Insider Trans | - | Shs Float | 0.03B | Perf Month | 5.89% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | -0.23 | Inst Own | 24.7% | Short Float | 0.68% | Perf Quarter | 46.36% |
| Income | -0.03B | P/S | 34.56 | EPS this Y | 7.89% | Inst Trans | - | Short Ratio | 0.04 | Perf Half Y | 87.3% |
| Sales | 0.00B | P/B | 0.71 | EPS next 5Y | 11.71% | ROA | -55.09% | Short Interest | 0.21M | Perf YTD | 1.93% |
| Book/sh | 0.83 | P/C | 0.68 | EPS past 3/5Y | 62.06% 66.27% | ROE | -66.96% | 52W High | -70.34% ($1.99) | Perf Year | -68.88% |
| Cash/sh | 0.87 | P/FCF | - | Sales past 3/5Y | 6.12% -51.39% | ROIC | -95.38% | 52W Low | 110.8% ($0.28) | Perf 3Y | -75.46% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 30.3% | Gross Margin | 95.96% | Volatility(W/M) | 4.01% 4.25% | Perf 5Y | -99.56% |
| Dividend TTM | - | EV/Sales | -16.33 | Sales Y/Y TTM | 13.77% | Oper. Margin | -5219.3% | ATR (14) | 0.02 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 12.53 | EPS Q/Q | 48.55% | Profit Margin | -4646.14% | RSI (14) | 53.29 | Recom | 2.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 12.53 | Sales Q/Q | 54.76% | SMA20 | -0.18% ($0.59) | Beta | 2 | Target Price | $2 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | 2.39% ($0.58) | Rel Volume | 0.05 | Prev Close | $0.59 |
| Employees | 10 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 1.9% 35.2% | SMA200 | -1.43% ($0.6) | Avg Volume(3M) | 5.22M | Price | $0.59 |
| IPO | 2018/1/25 | Option/Short | No/Yes | Trades | 420 | Volume | 244,987 | Change | 0.66% |
뉴스 로딩 중...